Howard M. Belmont, M.D.

Associate Professor of Medicine, New York University School of Medicine

Director, Lupus Clinic at Bellevue Hospital

Bellevue Hospital

Medical Director, Hospital for Joint Diseases, New York University Medical Center

Co-Director, Lupus Clinic at the Hospital for Joint Diseases

New York Hospital for Joint Diseases

New York, New York

 

 

Education

M.D., University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 1980

Residency

Internal Medicine, Mount Sinai School of Medicine, Mount Sinai Hospital, New York, New York, 1983

Fellowship

Rheumatology, New York University Medical Center-Bellevue Hospital, New York, New York, 1985

Board Certifications

American Board of Internal Medicine

Subspecialty: Rheumatology

 

Hospital Affiliations/Admitting Privileges

NYU Hospital for Joint Diseases

University Hospital of the New York University Medical Center

Bellevue Hospital, New York University Medical Center

 

Following Dr. Belmont’s medical degree at the University of Pittsburgh School of Medicine, he completed his residency at the Mount Sinai School of Medicine and a fellowship in Rheumatology at the New York University Medical Center-Bellevue Hospital.  Dr. Belmont’s expertise includes connective tissue disorders, gout, rheumatoid arthritis, Wegener’s Granulomatosis, systemic lupus erythematosus, antiphospholipid antibody syndrome, systemic vasculitis, and scleroderma.  His research interests include mechanisms of vascular injury in Systemic Lupus Erythematosus, the role of complement, adhesion molecules, nitric oxide and endothelial cells in SLE, and novel therapies for lupus nephritis. 

 

Dr. Belmont has written numerous publications, including articles in the Journal of Rheumatology, Arthritis & Rheumatology, Lupus, and the New England Journal of Medicine.  Additionally, Dr. Belmont is a Fellow of the American College of Rheumatology, a member of the Executive Committee of the New York Rheumatism Association, and on the Board of Governors of the New York Chapter Arthritis Foundation.  He is a leader in research and the clinical field of rheumatology.